Načítá se...
Plasma Osteoprotegerin Levels Before and After Treatment of Thyroid Dysfunctions
Purpose: Osteoprotegerin (OPG) is a soluble decoy receptor for the receptor activator of nuclear factor kappaB ligand, thereby inhibiting bone resorption. In this study, we aimed to evaluate plasma OPG levels in patients with thyroid dysfunctions and determine whether its levels change after restora...
Uloženo v:
Hlavní autoři: | , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Turkiye Klinikleri
2013-12-01
|
Edice: | Turkish Journal of Endocrinology and Metabolism |
Témata: | |
On-line přístup: | http://dx.doi.org/10.4274/Tjem.2238 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|